Posts by: Daniela Semedo, PhD

Daniela Semedo, PhD

Daniela holds a PhD in Clinical Psychology from The University of Edinburgh, United Kingdom, a MSc in Health Psychology and a BSc in Clinical Psychology. Her work has been focused on vulnerability to psychopathology and early identification and intervention in psychosis.

August 26, 2015August 28, 2015

Study Determines Efficacy And Safety of Leflunomide In Early Rheumatoid Arthritis Patients

News

Results from a recent study entitled “Efficacy and safety of weekly leflunomide for the treatment of early rheumatoid arthritis: a randomized, multi-center study”, published in the International Journal of Rheumatic Diseases, revealed ... Read more

August 6, 2015August 6, 2015

Probiotics Improve Behavioral Symptoms of Chronic Inflammatory Conditions, Including RA

News

In a recent study published in the Journal of Neuroscience, a team of researchers from the University of Calgary found that probiotics might be able to improve the behavioral symptoms of ... Read more

August 3, 2015August 6, 2015

Mood and Depressive Symptoms May Predict Momentary Pain Among Patients With Rheumatoid Arthritis

News

According to a recent study published in the Annals of Behavioral Medicine, mood and depressive symptoms may predict momentary pain among patients with rheumatoid arthritis (RA). “The results of this ... Read more

July 22, 2015July 22, 2015

Total Knee Replacement Beneficial For Rheumatoid Arthritis Patients

News

Even though the beneficial impact of total knee arthroplasty (TKA) on outcome measures such as knee pain and function in patients with rheumatoid arthritis (RA) has been well documented, studies ... Read more

July 15, 2015July 15, 2015

Researchers Discuss Evidence of Weight Loss as Predictor of Death in Rheumatoid Arthritis

News

In a recent review published in Nature Reviews Rheumatology, Naveed Sattar and Iain McInnes from the University of Glasgow provided insight on a recent a study published in the journal Arthritis & ... Read more

June 29, 2015June 29, 2015

Rheumatoid Arthritis Tofacitinib Restores Skin Color In Vitiligo Patient

News

Dermatologists at Yale School of Medicine recently discovered that a medication for Rheumatoid Arthritis (RA) was able to restore the skin color of a patient with vitiligo. The study was published ... Read more

June 26, 2015

Hospira Presents New Data at EULAR 2015 on Comparable Effectiveness and Safety of Inflectra in Rheumatic Diseases switched from Remicade

News

Hospira, Inc. a world leading company in biosimilars, recently announced its data from an independent study in which patients with rheumatic diseases had similar safety and clinical effectiveness after switching from Remicade to ... Read more

June 24, 2015June 24, 2015

Hepatitis B Vaccine Less Effective in Patients With Rheumatoid Arthritis

News

In a recent study published in the Annals of Rheumatic Diseases and presented during the Annual Meeting of the European League Against Rheumatism (EULAR 2015), a team of researchers found ... Read more

June 22, 2015June 23, 2015

Xencor Announces Complete Results Of Its XmAb5871 Program

News

Xencor, Inc. has recently announced the results from a Phase 1b/2a clinical of its XmAb5871 for patients with a diagnosis of rheumatoid arthritis (RA). XmAb5871 is a first-in-class monoclonal antibody that ... Read more

June 17, 2015June 17, 2015

Galapagos Announces Completion of DARWIN Studies Of Filgotinib in RA Patients

News

Galapagos NV a clinical stage Belgium-based biotech company, recently announced the last rheumatoid arthritis patients in its DARWIN 1 and 2 dose finding studies with filgotinib have completed their final visit. ... Read more